MedPath

Evaluation of ketamine in managing post operative pain following laproscopic cholecystectomy

Completed
Conditions
ASA I and II patients undergoing laproscopic cholecystectomy
Calculus of gallbladder without cholecystitis,
Registration Number
CTRI/2021/10/037604
Lead Sponsor
SMSR Sharda University
Brief Summary

Patients undergoing laparoscopic cholecystectomy (LC) experience lesser post-operative pain than conventional cholecystectomy. 1 However, pain remains the dominant complaint of   patients on the first post operative day.2,3  Effective post operative analgesia after LC has always remained a clinical challenge. This acute pain also predisposes the development of chronic pain at port sites in LC patients.

NMDA is a receptor for the excitatory neurotransmitter glutamate, which is released with noxious peripheral stimuli. The activation of NMDA receptors has been associated with hyperalgesia, neuropathic pain and chronic pain. Thus leading to the possibility that NMDA receptor antagonist may be useful in treatment of chronic pain. Ketamine, a NMDA antagonist may be used as an analgesic which can be used for acute as well as chronic pain in LC patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

ASA grade I and II patients of either sex, between 20-60 yrs of age, undergoing elective laparoscopic cholecystectomy under general anesthesia,.

Exclusion Criteria
  • The patients unable to understand NRS, allergic to local anesthetics, had chronic pain disease other than gall stone disease, choledocholithiasis, acute pancreatitis, or were pregnant, were excluded from the study.
  • Whenever surgical procedure necessitated the conversion of laproscopic cholysectomy to open procedure, such patients was also excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The length of time between extubation and the first request for pain medication was recorded.The length of time between extubation and the first request for pain medication was recorded. | Chronic pain will be asked from the patient every 15 days on telephone till 6 months post surgery.
Chronic pain (NRS score)will be asked from the patient every 15 days on telephone till 6 months.The length of time between extubation and the first request for pain medication was recorded. | Chronic pain will be asked from the patient every 15 days on telephone till 6 months post surgery.
Secondary Outcome Measures
NameTimeMethod
The total and cumulative consumption of analgesics (tramadol) will be recorded after 24 hours.24 hours
shoulder pain, nausea, vomiting were also recorded.24 hours

Trial Locations

Locations (1)

School of Medical sciences and Research

🇮🇳

Nagar, UTTAR PRADESH, India

School of Medical sciences and Research
🇮🇳Nagar, UTTAR PRADESH, India
Dr Shruti Jain
Principal investigator
9212308441
shruti.anaesth@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.